Industry update Landmark study first to show low-dose CBD doesn’t impair driving 'That’s great news for those using or considering treatment using CBD-based products,' says lead author Thomas Arkell Jared GnamDecember 1, 2020
Cannabis Global CBD report underscores need for low-dose clinical trials A detailed look at non-prescription cannabidiol in 9 countries reveals a regulatory hodgepodge outpaced by a wild west market Nick LabaSeptember 15, 2020